🇺🇸 FDA
Pipeline program

Influsplit Tetra 2024/2025 Injektionssuspension in Fertigspritze Influenza-Spaltimpfstoff (inaktiviert)

mRNA-1010-P304

Phase 3 small_molecule active

Quick answer

Influsplit Tetra 2024/2025 Injektionssuspension in Fertigspritze Influenza-Spaltimpfstoff (inaktiviert) for Influenza is a Phase 3 program (small_molecule) at Moderna Biotech Spain with 1 ClinicalTrials.gov record(s).

Program details

Company
Moderna Biotech Spain
Indication
Influenza
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials